Merck, a leading science and technology company in life science, helps customers advance production capabilities while increasing access to therapies for people worldwide. The development of an ADC requires expertise in small and large molecule handling, manufacturing, formulation and testing. Choosing an experienced partner, with these skills and the required containment facilities can help advance your ADC to market. Whether you are seeking to build your process based on our tailored technology platforms, a service provider – or a combination of both, we can collaborate with you. www.MerckMillipore.com/adcservices
BSP Pharmaceuticals is a Contract Development and Manufacturing Organization fully dedicated to antineoplastic drugs, designed to handle the complexity of biopharmaceutical products and offering customized services to support its client from development to commercial manufacturing of injectables and oral formulations. BSP Pharmaceuticals is focused on innovative therapies such as Proteosome Inhibitors, Antibody Drug Conjugates (ADCs) , Liposomal formulations, handling the major platforms of ADC compounds currently in clinical and commercial phase.
Molecular Templates is a clinical stage biopharmaceutical company focused on its Engineered Toxin Body (ETB) scaffold, a next-generation immunotoxin platform utilizing the unique biology of a de-immunized Shiga-like toxin (SLT-A). ETBs induce their own internalization, route to the cytosol, and enzymatically and irreversibly destroy ribosomes. Because ETBs route to the cytosol, additional payloads can be genetically or chemically conjugated to the ETB, including foreign class I antigens to stimulate a CD8 response to the tumor.
Sartorius-Stedim Biotech is a key supplier of Bioprocessing technologies and Biomanufacturing related services.
Benefit from the most comprehensive bioprocess and single-use technology portfolio coupled with our process engineering expertise, ensuring a robust process development and manufacturing approach… Read more
OcellO is an innovative biotech company offering services for drug discovery and early drug development. OcellO excels in clinically relevant in vitro 3D tumoroid assays, using Patient-derived xenograft (PDX) models and primary tumor cells (‘in vitro clinical trials’). We are experienced in working with…
Novasep provides unique services for the development and cGMP manufacture of antibody-drug conjugates including the payload, the linker and the monoclonal antibody. With a recent €10M investment in a fully integrated ADC facility, Novasep has reinforced its current ADC offering with full bio-conjugation services to meet increasing market demand.
For over 25 years, Lonza has been helping emerging biotech and pharmaceutical companies improve and advance their products. Whether you are in the early stages of clinical development or providing commercial product to patients around the globe, Lonza supplies complete development services, industry-leading manufacturing, and broad technology platforms that enable products to reach their full potential… Read More
European leader in analytical sciences – Quality Assistance S.A. is a leading European Contract Research Organisation providing the pharmaceutical industry with all the analytical services required by EMA and FDA regulations for the development and marketing of innovative human medicinal products. The company holds a unique position on the market thanks to having all its laboratories on one site, 160 highly qualified professionals and 35 years’ expertise at the forefront of analytical sciences.
SCIEX enables drug discovery and development for biologics and small molecule drugs. From identification through peptide mapping and sequence variance analysis ― our advanced LC/MS, LC/MS/MS and CE solutions reduce complexity across the entire process. SCIEX strives to exceed expectations and empower customers to find accurate answers.